Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles
Source abstract
Abstract
Upon administration, nanoparticles (NPs) are exposed to biological fluids from which they adsorb proteins and other biomolecules to form a “protein corona”. NP–protein interactions are still poorly understood and quantitative studies to characterize them remain scarce. Here, we have investigated the effect of neutral dioleoylphosphatidylethanolamine (DOPE) and cholesterol on the adsorption of human plasma proteins onto the surface of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-based cationic liposomes of 100 nm in diameter. Quantitative analysis of the protein corona revealed that replacing cationic DOTAP lipids with neutral lipids, being indifferently DOPE or cholesterol, reduces the affinity of fibrinogen, prothrombin, vitamin K, and vitronectin for the lipid surface. On the other side, DOPE specifically promotes the adsorption of apolipoproteins and serum albumin, while cholesterol induces the preferential binding of immunoglobulins and complement proteins. The results of this study will help to explain why NPs of different lipid compositions have a dramatic difference in their in vivo transfection efficiency and will be useful for design of lipid NPs with optimal circulation profiles.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery · Membrane Separation Technologies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (63)
Show source-provided references
1. Abe Y, Kuroda Y, Kuboki N, Matsushita M, Yokoyama N, Kojima N (2008) Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages. J Biochem 144:563–57010.1093/jb/mvn101 ↗
2. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818e2210.1126/science.1095833 ↗
3. Amenitsch H, Caracciolo G, Foglia P, Fuscoletti V, Giansanti P, Marianecci C, Pozzi D, Laganà A (2011) Existence of hybrid structures in cationic liposome/DNA complexes revealed by their interaction with plasma proteins. Colloids Surf B 82:141–14610.1016/j.colsurfb.2010.08.030 ↗
4. Bisgaier CL, Siebenkas MV, Williams KJ (1989) Effects of apolipoproteins A-IV and A-I on the uptake of phospholipid liposomes by hepatocytes. J Biol Chem 264:862–86610.1016/S0021-9258(19)85022-6 ↗
5. Caminiti R, Caracciolo G, Pisani M (2005) Effect of hydration on the structure of oriented lipid membranes investigated by in situ time-resolved Energy Dispersive X-ray Diffraction. Appl Phys Lett 86:253902–25390410.1063/1.1952583 ↗
6. Capriotti AL, Caracciolo G, Caruso G, Cavaliere C, Pozzi D, Samperi R, Laganà A (2010) Analysis of plasma proteins adsorption onto DC-Chol-DOPE cationic liposomes by HPLC-CHIP coupled to a Q-TOF mass spectrometer. Anal Bioanal Chem 398:2895–290310.1007/s00216-010-4104-y ↗
7. Capriotti AL, Caracciolo G, Caruso G, Foglia P, Pozzi D, Samperi R, Laganà A (2011a) Differential analysis of “protein corona” profile adsorbed onto different nonviral gene delivery systems. Anal Biochem 419:180–18910.1016/j.ab.2011.08.003 ↗
8. Capriotti AL, Caracciolo G, Caruso G, Foglia P, Pozzi D, Samperi R, Laganà A (2011b) DNA affects the composition of lipoplex protein corona: a proteomics approach. Proteomics 11:3349–335810.1002/pmic.201000803 ↗
9. Capriotti AL, Caracciolo G, Cavaliere C, Crescenzi C, Pozzi D, Laganà A (2011c) Shotgun proteomics analytical approach for studying proteins adsorbed onto liposome surface. Anal Bioanal Chem 401:1195–120210.1007/s00216-011-5188-8 ↗
10. Capriotti AL, Caracciolo G, Caruso G, Cavaliere C, Pozzi D, Samperi R, Laganà A (2012a) Label-free quantitative analysis for studying the interactions between nanoparticles and plasma proteins. Anal Bioanal Chem. doi: 10.1007/s00216-011-5691-y
11. Capriotti AL, Caracciolo G, Cavaliere C, Foglia P, Pozzi D, Samperi R, Laganà A (2012b) Do plasma proteins distinguish between liposomes of varying charge density? J Proteomics 75:1924–193210.1016/j.jprot.2012.01.003 ↗
12. Caracciolo G (2012) The protein corona effect for targeted drug delivery. Bioinspired Biomim Nanobiomater. doi: 10.1680/bbn.12.00027
13. Caracciolo G, Caminiti R (2005) Do DC-Chol/DOPE-DNA complexes really form an inverted hexagonal phase? Chem Phys Lett 411:327–33210.1016/j.cplett.2005.06.070 ↗
14. Caracciolo G, Caminiti R, Pozzi D, Friello M, Boffi F, Congiu Castellano A (2002) Self-Assembly of cationic liposomes-DNA: a structural and thermodynamic study by Energy Dispersive X-ray Diffraction. Chem Phys Lett 351:222–22810.1016/S0009-2614(01)01391-4 ↗
15. Caracciolo G, Pozzi D, Amenitsch H, Caminiti R (2006) One dimensional thermotropic dilatation area of lipid headgroups within lamellar lipoplexes. Langmuir 22:4267–427310.1021/la0534423 ↗
16. Caracciolo G, Pozzi D, Amenitsch H, Caminiti R (2007) Interaction between lipoplexes and cellular lipids resulting in DNA release is a two-stage process. Langmuir 23:8713–871710.1021/la7017665 ↗
17. Caracciolo G, Pozzi D, Caminiti R, Marchini C, Montani M, Amici A, Amenitsch H (2008) Enhanced transfection efficiency of multicomponent lipoplexes in the regime of optimal membrane charge density. J Phys Chem B 112:11298–1130410.1021/jp803077n ↗
18. Caracciolo G, Caminiti R, Digman MA, Gratton E, Sanchez S (2009) Efficient escape from endosomes determines the superior efficiency of multicomponent lipoplexes. J Phys Chem B 113:4995–499710.1021/jp811423r ↗
19. Caracciolo G, Pozzi D, Capriotti AL, Marianecci C, Carafa M, Marchini C, Montani M, Amici A, Amenitsch H, Digman MA, Gratton E, Sanchez SS, Laganà A (2011a) Factors determining the superior performance of lipid/DNA/protammine nanoparticles over lipoplexes. J Med Chem 54:4160–417110.1021/jm200237p ↗
20. Caracciolo G, Pozzi D, Candeloro De Sanctis S, Capriotti AL, Caruso G, Samperi R, Laganà A (2011b) Effect of membrane charge density on the protein corona of cationic liposomes: interplay between cationic charge and surface area. Appl Phys Lett 99:03370210.1063/1.3615055 ↗
21. Caracciolo G, Pozzi D, Capriotti AL, Cavaliere C, Cardarelli F, Bifone A, Bardi G, Salomone F, Laganà A (2012) Cancer cell targeting of lipid gene vectors by protein corona. In: Nanotech Conference and Expo 2012: technical proceedings of the 2012 NSTI nanotechnology conference and expo, 18–21 June 2012. Santa Clara Convention Center, Santa Clara, pp 354–357
22. Cedervall T, Lynch I, Foy M, Berggard T, Donnelly SC, Cagney G, Linse S, Dawson KA (2007) Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 46:5754–575610.1002/anie.200700465 ↗
23. Dell’Orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S (2010) Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS ONE 5(6):e1094910.1371/journal.pone.0010949 ↗
24. Duncan B, Kim C, Rotello VM (2010) Gold nanoparticle platforms as drug and biomacromolecule delivery systems. J Control Release 148:122–12710.1016/j.jconrel.2010.06.004 ↗
25. Even-Chen S, Cohen R, Barenholz Y (2012) Factors affecting DNA binding and stability of association to cationic liposomes. Chem Phys Lipids 165:414–42310.1016/j.chemphyslip.2012.03.006 ↗
26. Frisken BJ (2001) Revisiting the method of cumulants for the analysis of dynamic light-scattering data. Appl Opt 40:4087–409110.1364/AO.40.004087 ↗
27. Gessner A, Lieske A, Paulke B, Müller R (2002) Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 54:165–17010.1016/S0939-6411(02)00081-4 ↗
28. Gessner A, Lieske A, Paulke BR, Muller RH (2003) Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res A 65:319–32610.1002/jbm.a.10371 ↗
29. Gjetting T, Arildsen NS, Christensen CL, Poulsen TT, Roth JA, Handlos VN, Poulsen HS (2010) In vitro and in vivo effects of polyethylene glycol mediated gene transfection. Int J Nanomed 5:371–383
30. Han G, Ghosh P, De M, Rotello VM (2007a) Drug and gene delivery using gold nanoparticles. Nanobiotechnology 3:40–4510.1007/s12030-007-0005-3 ↗
31. Han G, Ghosh P, Rotello VM (2007b) Functionalized gold nanoparticles for drug delivery. Nanomedicine 2:113–12310.2217/17435889.2.1.113 ↗
32. Ishida T, Kojima H, Harashima H, Kiwada H (2000) Biodistribution of liposomes and C3 fragments associated with liposomes: evaluation of their relationship. Int J Pharm 205:183–19310.1016/S0378-5173(00)00511-1 ↗
33. Ishida T, Harashima H, Kiwada H (2002) Liposome clearance. Biosci Rep 22:197–22410.1023/A:1020134521778 ↗
34. Kim S, Shin D, Lee H, Ahn B-Y, Yoon Y, Kim M (2009) Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. J Hepatol 50:479–48810.1016/j.jhep.2008.10.029 ↗
35. Kim SK, Foote MB, Huang L (2012) The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials 33:3959–396610.1016/j.biomaterials.2012.02.010 ↗
36. Kuntsche J, Horst JC, Bunjes H (2011) Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems. Int J Pharm 417:120–13710.1016/j.ijpharm.2011.02.001 ↗
37. Kwon OJ, Kang E, Kim S, Yun CO (2011) Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery. J Control Release 155:317–32510.1016/j.jconrel.2011.06.014 ↗
38. Lesniak A, Campbell A, Monopoli M, Lynch I, Salvati A, Dawson KA (2010) Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials 36:9511–951810.1016/j.biomaterials.2010.09.049 ↗
39. Lundqvist M, Stigler J, Cedervall T, Elia G, Lynch I, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–1427010.1073/pnas.0805135105 ↗
40. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, Elia G, Dawson KA (2011) The evolution of the protein corona around nanoparticles: a test study. ACS Nano 5:7503–750910.1021/nn202458g ↗
41. Lynch I, Dawson KA (2008) Protein–nanoparticle interactions. Nano Today 3:40–4710.1016/S1748-0132(08)70014-8 ↗
42. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA (2007) The nanoparticle–protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134–135:167–17410.1016/j.cis.2007.04.021 ↗
43. Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA (2012) Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”. J Control Release 161:164–17410.1016/j.jconrel.2012.04.009 ↗
44. Marchini C, Pozzi D, Montani M, Alfonsi C, Amici A, Candeloro De Sanctis S, Digman MA, Sanchez S, Gratton E, Amenitsch H, Fabbretti A, Gualerzi CO, Caracciolo G (2011) Role of temperature-independent lipoplex–cell membrane interactions in the efficiency boost of multicomponent lipoplexes. Cancer Gene Ther 18:543–55210.1038/cgt.2011.12 ↗
45. McLaughlin S, Whitaker M (1988) Cations that alter surface potentials of lipid bilayers increase the calcium requirement for exocytosis in sea urchin eggs. J Physiol 396:189–20410.1113/jphysiol.1988.sp016958 ↗
46. Moghimi SM, Patel HM (1988) Tissue specific opsonins for phagocytic cells and their different affinity for cholesterol-rich liposomes. FEBS Lett 233:143–14710.1016/0014-5793(88)81372-3 ↗
47. Monopoli MP, Baldelli Bombelli F, Dawson KA (2011a) Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol 6:11–1210.1038/nnano.2010.267 ↗
48. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli Bombelli F, Dawson KA (2011b) Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–253410.1021/ja107583h ↗
49. Morita SY, Sakurai A, Nakano M, Kitagawa S, Handa T (2011) Presence of apolipoprotein C-III attenuates apolipoprotein E-mediated cellular uptake of cholesterol-containing lipid particles by HepG2 cells. Lipids 46:323–33210.1007/s11745-010-3498-9 ↗
50. Pitek AS, O’Connell D, Mahon E, Monopoli MP, Baldelli Bombelli F, Dawson KA (2012) Transferrin coated nanoparticles: study of the bionano interface in human plasma. PLoS ONE 7:e4068510.1371/journal.pone.0040685 ↗
51. Pozzi D, Amenitsch H, Caminiti R, Caracciolo G (2006) How lipid hydration and temperature affect the structure of DC-Chol/DOPE/DNA lipoplexes. Chem Phys Lett 422:439–44510.1016/j.cplett.2006.02.106 ↗
52. Pozzi D, Marchini C, Cardarelli F, Amenitsch H, Garulli C, Bifone A, Caracciolo G (2012) Transfection efficiency boost of cholesterol-containing lipoplexes. Biochim Biophys Acta 1818:2335–234310.1016/j.bbamem.2012.05.017 ↗
53. Puri A, Loomis K, Smith B, Lee J-H, Yavlovich A, Heldman E, Blumenthal R (2009) Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carr Syst 26:523–58010.1615/CritRevTherDrugCarrierSyst.v26.i6.10 ↗
54. Sandin P, Fitzpatrick LW, Simpson JC, Dawson KA (2012) High-speed imaging of rab family small GTpases reveals rare events in nanoparticle trafficking in living cells. ACS Nano 6:1513–152110.1021/nn204448x ↗
55. Scieszka JF, Maggiora LL, Wright SD, Cho MJ (1991) Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils. Pharm Res 8:65–6910.1023/A:1015830306839 ↗
56. Simberg D, Danino D, Talmon Y, Minsky A, Ferrari ME, Wheeler CJ, Barenholz Y (2001) Phase behavior, DNA ordering, and size instability of cationic lipoplexes relevance to optimal transfection activity. J Biol Chem 276:47453–4745910.1074/jbc.M105588200 ↗
57. Simberg D, Weisman S, Talmon Y, Faerman A, Shoshani T, Barenholz Y (2003) The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J Biol Chem 278:39858–3986510.1074/jbc.M302232200 ↗
58. Simberg D, Weiss A, Barenholz Y (2005) Reversible mode of binding of serum proteins to DOTAP/cholesterol lipoplexes: a possible explanation for intravenous lipofection efficiency. Hum Gene Ther 16:1087–109610.1089/hum.2005.16.1087 ↗
59. Stark WJ (2011) Nanoparticles in biological systems. Angew Chem Int Ed Engl 50:1242e5810.1002/anie.200906684 ↗
60. Wagner A, Vorauer-Uhl K (2011) Liposome technology for industrial purposes. J Drug Deliv 2011:59132510.1155/2011/591325 ↗
61. Williams KJ, Werth VP, Wolff JA (1984) Intravenously administered lecithin liposomes: a synthetic antiatherogenic lipid particle. Perspect Biol Med 27:417–43110.1353/pbm.1984.0031 ↗
62. Yoshikawa N, Sakamoto K, Mizuno S, Sakaguchi J, Miyamoto H, Mine T, Sasaki H, Fumoto S, Nishida K (2011) Multiple components in serum contribute to hepatic transgene expression by lipoplex in mice. J Gene Med 13:632–64310.1002/jgm.1618 ↗
63. Zybailov B, Mosley AL, Sardiu ME, Coleman MK, Florens L, Washburn MP (2006) Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 5:2339–234710.1021/pr060161n ↗